Sojournix
About:
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
Website: https://sojournixpharma.com/
Top Investors: RA Capital Management, Janus Henderson Investors, Frazier Healthcare Partners, Boxer Capital, Venrock Healthcare Capital Partners
Description:
Sojournix, Inc. is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
Total Funding Amount:
$70M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Arlington, Massachusetts, United States
Founded Date:
2016-01-01
Contact Email:
info(AT)sojournixpharma.com
Founders:
Daniel Grau
Number of Employees:
11-50
Last Funding Date:
2019-01-04
IPO Status:
Private
Industries:
© 2025 bioDAO.ai